Marshall University Joan C. Edwards School of Medicine Huntington, WV, United States
Adnan A. Khan, MD1, Yousaf B. Hadi, MD2, Syeda F. Naqvi, MD2, Raja Samir Khan, MD2, Rida Jannat, MD2, Ali Younas Khan, MD3, Armaghan Mansoor, MD2, Ashwani Singal, MD, FACG4, Justin Kupec, MD, FACG5 1Marshall University Joan C. Edwards School of Medicine, Huntington, WV; 2West Virginia University School of Medicine, Morgantown, WV; 3Saint Joseph Mercy Oakland, Pontiac, MI; 4University of South Dakota Sanford School of Medicine, Sioux Falls, SD; 5West Virginia University, Morgantown, WV
Introduction: Administration of antibiotics in patients with cirrhosis and upper-gastrointestinal bleeding has been shown to improve outcomes, however, little is known regarding optimum duration of treatment. Seven days are generally recommended, but antibiotic duration has not been compared to clinical outcomes in current literature. We aimed to study the effect of shorter prophylactic antibiotic duration on patient outcomes.
Methods: We conducted a retrospective cohort study of patients with cirrhosis presenting with upper-gastrointestinal bleeding at our institute from 2010 to 2018. Patients were divided into three cohorts based on duration of prophylactic antibiotics administered: 1-3 days, 4-6 days, and 7 or more days of antibiotics. Rates of infection diagnosis within 30 days, time to infection, rebleeding, and mortality were compared between the three groups with Chi-square, Fisher Exact and Kruskall-Wallace tests. Multivariable analysis was conducted to evaluate independent risk factors for infection.
Results: A total of 243 patients with cirrhosis and upper-gastrointestinal bleed were included in our analysis. The three groups were well-matched in demographic and clinical variables. Twenty-seven patients developed infections within 30 days of bleed. MELD score and presence of ascites were associated with infection within 30 days. There was no significant difference in the rates of infection, time to infection, early re-bleeding, late re-bleeding, and in-hospital mortality between the three groups.
Discussion: Short course of antibiotics for prophylaxis (3 days) appears safe and adequate for prophylaxis in patients with cirrhosis with upper gastrointestinal bleeding if bleeding has abated and there is no active infection.
Disclosures: Adnan Khan indicated no relevant financial relationships. Yousaf Hadi indicated no relevant financial relationships. Syeda Naqvi indicated no relevant financial relationships. Raja Samir Khan indicated no relevant financial relationships. Rida Jannat indicated no relevant financial relationships. Ali Younas Khan indicated no relevant financial relationships. Armaghan Mansoor indicated no relevant financial relationships. Ashwani Singal indicated no relevant financial relationships. Justin Kupec indicated no relevant financial relationships.
Adnan A. Khan, MD1, Yousaf B. Hadi, MD2, Syeda F. Naqvi, MD2, Raja Samir Khan, MD2, Rida Jannat, MD2, Ali Younas Khan, MD3, Armaghan Mansoor, MD2, Ashwani Singal, MD, FACG4, Justin Kupec, MD, FACG5. P1789 - Antibiotic Prophylaxis for Upper Gastrointestinal Bleed in Liver Cirrhosis; Less May Be More, ACG 2021 Annual Scientific Meeting Abstracts. Las Vegas, Nevada: American College of Gastroenterology.